Tahany Awad

Tahany Awad

Auto-generated profile, based on publicly available information

Tahany Awad

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Department 7812, Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KTKristian Thorlund
Kristian Thorlund
GIGeorgina Imberger
Georgina Imberger
BJBradley C. Johnston
Bradley C. Johnston
MWMichael Walsh
Michael Walsh
TATahany Awad
Tahany Awad
JWJørn Wetterslev
Jørn Wetterslev
Assessment of heterogeneity is essential in systematic reviews and meta-analyses of clinical trials. The most commonly used heterogeneity measure, I2, provides an estimate of the proportion of variability in a meta-analysis that is explained by differences between the included trials rather than by sampling error. Recent studies have raised concerns about the reliability of I2 estimates, due to their dependence on the precision of included trials and time-dependent biases. Authors have also advocated use of 95% confidence intervals (CIs) to express the uncertainty associated with I2 estimates. However, no previous studies have explored how many trials and events are required to ensure stable and reliable I2 estimates, or how 95% CIs perform as evidence accumulates. To assess the stability and reliability of I2 estimates and their 95% CIs, in relation to the cumulative number of trials and events in meta-analysis, we looked at 16 large Cochrane meta-analyses - each including a sufficient number of trials and events to reliably estimate I2 - and monitored the I2 estimates and their 95% CIs for each year of publication. In 10 of the 16 meta-analyses, the I2 estimates fluctuated more than 40% over time. The median number of events and trials required before the cumulative I2 estimates stayed within +/−20% of the final I2 estimate was 467 and 11. No major fluctuations were observed after 500 events and 14 trials. The 95% confidence intervals provided good coverage over time. I2 estimates need to be interpreted with caution when the meta-analysis only includes a limited number of events or trials. Confidence intervals for I2 estimates provide good coverage as evidence accumulates, and are thus valuable for reflecting the uncertainty associated with estimating I2.

19 May 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KTKristian Thorlund
Kristian Thorlund
TATahany Awad
Tahany Awad
GBGuy Boivin
Guy Boivin
LTLehana Thabane
Lehana Thabane
Antivirals play a critical role in the prevention and the management of influenza. One class of antivirals, neuraminidase inhibitors (NAIs), is effective against all human influenza viruses. Currently there are two NAI drugs which are licensed worldwide: oseltamivir (Tamiflu®) and zanamivir (Relenza®); and two drugs which have received recent approval in Japan: peramivir and laninamivir. Until recently, the prevalence of antiviral resistance has been relatively low. However, almost all seasonal H1N1 strains that circulated in 2008-09 were resistant to oseltamivir whereas about 1% of tested 2009 pandemic H1N1 viruses were found to be resistant to oseltamivir. To date, no studies have demonstrated widespread resistance to zanamivir. It seems likely that the literature on antiviral resistance associated with oseltamivir as well as zanamivir is now sufficiently comprehensive to warrant a systematic review.

1 April 2010 in Hepatology
Verified
Journal Article
Closed access
PDF file
TATahany Awad
Tahany Awad
KTKristian Thorlund
Kristian Thorlund
GHGoran Hauser
Goran Hauser
DŠDavor Štimac
Davor Štimac
MMMahasen Mabrouk
Mahasen Mabrouk
CGChristian Nyfeldt Gluud
Christian Nyfeldt Gluud


22 June 2012 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
NSNancy Santesso
Nancy Santesso
HSHolger Schünemann
Holger Schünemann
PBPaul Blumenthal
Paul Blumenthal
HVHugo De Vuyst
Hugo De Vuyst
JGJulia Gage
Julia Gage
NBNathalie Broutet
Nathalie Broutet

28 February 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
GHGoran Hauser
Goran Hauser
TATahany Awad
Tahany Awad
JBJesper Brok
Jesper Brok
KTKristian Thorlund
Kristian Thorlund
DŠDavor Štimac
Davor Štimac
LGLise Lotte Gluud
Lise Lotte Gluud